An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 114, Issue 1, Pages 37-43
Publisher
Springer Nature
Online
2015-12-18
DOI
10.1038/bjc.2015.433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of IL-33/ST2L signals in the immune cells
- (2015) Jingli Lu et al. IMMUNOLOGY LETTERS
- IL-33 activates tumor stroma to promote intestinal polyposis
- (2015) Rebecca L. Maywald et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis
- (2014) L. Barrera et al. ANNALS OF ONCOLOGY
- Correlations Between Serum IL33 and Tumor Development: a Meta-analysis
- (2014) Xiang-Jun Chen et al. Asian Pacific Journal of Cancer Prevention
- IL-33/ST2 pathway contributes to metastasis of human colorectal cancer
- (2014) Xuejian Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer
- (2014) Guanglin Cui et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
- (2014) Dominik Bergis et al. Translational Oncology
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of Interleukin-33 in Serum and Carcinoma Tissue from Patients with Hepatocellular Carcinoma and its Clinical Implications
- (2013) P Zhang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
- (2013) Kuan-Min Fang et al. NEURO-ONCOLOGY
- Macrophages
- (2013) Sofia Edin et al. OncoImmunology
- Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
- (2012) Caterina Musolino et al. BRITISH JOURNAL OF HAEMATOLOGY
- Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
- (2012) Mamdouh A K Sedhom et al. GUT
- Serum Interleukin-33 Levels in Patients with Gastric Cancer
- (2011) Pinghu Sun et al. DIGESTIVE DISEASES AND SCIENCES
- IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+T cells
- (2011) Qianting Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis
- (2011) J Gillibert-Duplantier et al. ONCOGENE
- Nuclear expression of interleukin-33 in pancreatic stellate cells
- (2010) Atsushi Masamune et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
- (2010) Luca Pastorelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started